We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.88B
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+32.38%
3 Year Est. Return
+99.93%
5 Year Est. Return
+115.9%
10 Year Est. Return
+395.26%
AUM
$807M
AUM Growth
+$40.8M
Cap. Flow
+$16.3M
Cap. Flow %
2.02%
Top 10 Hldgs %
17.11%
Holding
932
New
112
Increased
378
Reduced
301
Closed
51

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$1.34M
2
IYR icon
iShares US Real Estate ETF
IYR
+$1.18M
3
BCML icon
BayCom
BCML
+$1.11M
4
D icon
Dominion Energy
D
+$970K
5
NVDA icon
NVIDIA
NVDA
+$955K

Sector Composition

Rank Sector Weight
1 Technology 12.08%
2 Financials 10.28%
3 Healthcare 10.1%
4 Consumer Discretionary 9.01%
5 Industrials 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIMT
576
DELISTED
Aimmune Therapeutics
AIMT
$269K 0.03%
9,998
+824
+9% +$25.2K
NVEE
577
DELISTED
NV5 Global
NVEE
$268K 0.03%
15,476
-8,012
-34% -$125K
CI icon
578
Cigna
CI
$78.4B
$267K 0.03%
1,568
-78
-5% -$13.5K
JHA
579
DELISTED
Nuveen High Inc Dec 2018 Tgt Trm
JHA
$267K 0.03%
27,069
+5,900
+28% +$58K
NWL icon
580
Newell Brands
NWL
$2.21B
$266K 0.03%
+10,297
New +$268K
FEI
581
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
$266K 0.03%
20,400
-283
-1% -$3.61K
PRTK
582
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$266K 0.03%
26,050
+15,000
+136% +$170K
FIVE icon
583
Five Below
FIVE
$11.6B
$265K 0.03%
+2,712
New +$218K
LRCX icon
584
Lam Research
LRCX
$316B
$264K 0.03%
15,270
+4,380
+40% +$84.4K
SPSM icon
585
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$16.9B
$264K 0.03%
+8,174
New +$258K
DAR icon
586
Darling Ingredients
DAR
$9.32B
$263K 0.03%
13,242
-1,880
-12% -$34.1K
FPF
587
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.07B
$263K 0.03%
12,184
+87
+0.7% +$1.93K
BMRN icon
588
BioMarin Pharmaceuticals
BMRN
$11.9B
$262K 0.03%
+2,780
New +$243K
TLT icon
589
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
$262K 0.03%
2,151
+145
+7% +$17.3K
ICPT
590
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$262K 0.03%
3,117
-2,605
-46% -$191K
DBRG icon
591
DigitalBridge
DBRG
$2.92B
$261K 0.03%
10,476
+79
+0.8% +$1.89K
SCZ icon
592
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.1B
$261K 0.03%
4,166
+34
+0.8% +$2.23K
THC icon
593
Tenet Healthcare
THC
$22.2B
$261K 0.03%
+7,771
New +$242K
CXO
594
DELISTED
CONCHO RESOURCES INC.
CXO
$261K 0.03%
+1,883
New +$269K
HTD
595
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$912M
$260K 0.03%
11,108
CLF icon
596
Cleveland-Cliffs
CLF
$6.49B
$259K 0.03%
30,695
-2,875
-9% -$22.9K
FCRD
597
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$259K 0.03%
33,094
-1,984
-6% -$15.7K
CTB
598
DELISTED
Cooper Tire & Rubber Co.
CTB
$259K 0.03%
9,858
DG icon
599
Dollar General
DG
$28.4B
$258K 0.03%
2,619
-70
-3% -$6.73K
ANDV
600
DELISTED
Andeavor
ANDV
$258K 0.03%
1,969
-558
-22% -$73.5K

Similar funds

Wedbush Securities's Q2 2018 Portfolio in Review

As of Q2 2018, Wedbush Securities held 932 positions worth $807M, up 5.3% from $766M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Wedbush Securities's Q2 2018 filing shows 112 new, 378 increased, 301 reduced and 51 closed positions. Its largest new stake was BayCom: 46,324 shares worth $1.15M. The largest sale was GGP Inc., an estimated $2.55M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Wedbush Securities's largest Q2 2018 buy was BayCom: 46,324 shares worth $1.15M.
  • Wedbush Securities added most to AT&T in Q2 2018, an estimated $1.34M increase.
  • Wedbush Securities's biggest Q2 2018 reduction was GGP Inc., cutting an estimated $2.55M.
  • Wedbush Securities fully exited Time Warner Inc in Q2 2018, selling an estimated $999K.
  • Wedbush Securities's ten largest holdings make up 17% of its $807M portfolio in Q2 2018.
  • Wedbush Securities opened 112 new positions and closed 51 in Q2 2018.
  • Wedbush Securities's portfolio value rose 5.3% quarter-over-quarter to $807M.

Based on Wedbush Securities's 13F filing for Q2 2018, filed 3 Aug 2018.